论文部分内容阅读
目的观察特布他林与布地奈德雾化吸入治疗慢性支气管炎的临床效果。方法将80例慢性支气管炎患者随机分为观察组与对照组各40例。2组均给予解痉平喘及抗感染等综合基础治疗,观察组则给予适量布地奈德与特布他林经超声雾化吸入治疗,对照组接受地塞米松与糜蛋白酶雾化吸入治疗。比较2组临床疗效。结果观察组患者治疗总有效率为97.5%高于对照组的80.0%,差异有统计学意义(P<0.05)。结论对慢性支气管炎患者应用特布他林与布地奈德超声雾化吸入治疗,效果确切,值得临床推广应用。
Objective To observe the clinical effects of terbutaline and budesonide inhalation on chronic bronchitis. Methods 80 patients with chronic bronchitis were randomly divided into observation group and control group, 40 cases each. Both groups were given basic treatment of antispasmodic and antiasthmatic and anti-infective. The observation group was given budesonide and terbutaline by ultrasonic atomization inhalation. The control group received dexamethasone and chymotrypsin inhalation. The clinical efficacy of two groups were compared. Results The total effective rate of observation group was 97.5% higher than 80.0% of control group, the difference was statistically significant (P <0.05). Conclusions The application of terbutaline and budesonide ultrasonic nebulization in patients with chronic bronchitis is effective and worthy of clinical application.